High
5.640
Open
5.540
VWAP
5.14
Vol
2.17M
Mkt Cap
412.17M
Low
4.900
Amount
11.15M
EV/EBITDA(TTM)
5.89
Total Shares
76.16M
EV
474.72M
EV/OCF(TTM)
10.42
P/S(TTM)
1.11
Aspen Aerogels, Inc. is an aerogel technology company, which provides sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of re...Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
82.75M
-12.44%
-0.070
-714.04%
90.87M
-22.84%
0.026
-87.62%
102.48M
-12.67%
0.056
-70.59%
Estimates Revision
The market is revising Downward the revenue expectations for Aspen Aerogels, Inc. (ASPN) for FY2025, with the revenue forecasts being adjusted by -19.51% over the past three months. During the same period, the stock price has changed by -61.85%.
Revenue Estimates for FY2025
Revise Downward

-19.51%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-74.61%
In Past 3 Month
Stock Price
Go Down

-61.85%
In Past 3 Month
8 Analyst Rating

198.80% Upside
Wall Street analysts forecast ASPN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPN is 15.00 USD with a low forecast of 11.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
0 Sell
Strong Buy

198.80% Upside
Current: 5.020

Low
11.00
Averages
15.00
High
22.00
Barclays
David Anderson
Buy
Maintains
$25 → $13
2025-02-19
Reason
Barclays analyst J. David Anderson lowered the firm's price target on Aspen Aerogels to $13 from $25 and keeps an Overweight rating on the shares. The firm says that as a supplier of thermal barrier protection for electric vehicle batteries, the EV demand outlook has "meaningfully shifted" under President Trump, forcing Aspen to shift its expansion plans to a piecemeal approach relying on external manufacturing.
B. Riley Securities
Ryan Pfingst
Strong Buy
Maintains
$35 → $22
2025-02-19
Reason
B. Riley lowered the firm's price target on Aspen Aerogels to $22 from $35 and keeps a Buy rating on the shares following the Q4 earnings report. B. Riley believes Q1 will represent the trough for the EV business, though commentary from management suggested a cautious approach to the rest of 2025, the analyst tells investors in a research note. The firm believes the stock reflects value of less than $3 per share for the Thermal Barrier business at current levels.
Roth MKM
Chip Moore
Strong Buy
Maintains
$22 → $16
2025-02-14
Reason
Roth MKM analyst Chip Moore lowered the firm's price target on Aspen Aerogels to $16 from $22 but keeps a Buy rating on the shares after its Q4 results and below-consensus Q1 guide. Regulatory/macro uncertainty limits near-term visibility, but there is little current downside potential and the stock represents an attractive longer-term opportunity, the analyst tells investors in a research note. Proactive cost actions also look to support underlying profitability, Roth adds.
Craig-Hallum
Eric Stine
Strong Buy
Maintains
$21 → $18
2025-02-14
Reason
Craig-Hallum lowered the firm's price target on Aspen Aerogels (ASPN) to $18 from $21 and keeps a Buy rating on the shares following what the firm calls "a very eventful end to 2024." Q4 results were "solid," but Q1 was guided below the Street and no guidance for 2025 was given in light of the timing uncertainty of when General Motors' (GM) excess inventory clears and near-term headwinds in overall electric vehicle markets, notes the analyst, who views Aspen as positioned with a much less capital intensive business with a strong balance sheet and an outlook for improved cash generation.
Canaccord Genuity
George Gianarikas
Strong Buy
Maintains
$20 → $15
2025-02-14
Reason
Canaccord lowered the firm's price target on Aspen Aerogels to $15 from $20 and keeps a Buy rating on the shares. The firm said despite gross margin guiding for continued growth in 2025 EVs, Aspen is experiencing some inventory digestion in 1Q25 and as a result Canaccord is modeling a modest recovery off these levels for the rest of 2025.
Seaport Global
Tom Curran
Strong Buy
to
Hold
Downgrades
n/a
2025-02-13
Reason
Seaport Research downgraded Aspen Aerogels to Neutral from Buy after its Q4 earnings and below-consensus guidance. The firm's conviction in the company's EVTB - EV Thermal Barriers - division's ability to sustain both top line growth and recent margin is waning given the wide expected Q1 margin range and absence of any post-Q1 revenue or profit forecasts, along with the allusion to a tighter relationship between its PyroThin order volume and the associated customer EV program's unit sales, the analyst tells investors in a research note. Seaport adds it is particularly concerned about ramp expectations for second-half ramp for EVTB's contracts with ACC - the JV between Stellantis, Mercedes-Benz and TotalEnergies - the firm added.
Canaccord Genuity
George Gianarikas
Strong Buy
Maintains
$28 → $20
2025-01-16
Reason
Canaccord lowered the firm's price target on Aspen Aerogels to $20 from $28 and keeps a Buy rating on the shares. The firm adjusted its model to capture some of the uncertainties ahead yet values it a premium to peers based on its strong growth potential beyond 2027 through its numerous OEM relationships, competitive moat, strong balance sheet, and potential for healthy FCF generation.
Barclays
David Anderson
Buy
Maintains
$27 → $25
2024-11-12
Reason
Barclays lowered the firm's price target on Aspen Aerogels to $25 from $27 and keeps an Overweight rating on the shares. The company reported "another impressive quarter" and a 50% raise to its 2024 EBITDA guide provide further evidence this is one of the best new energy stories, "and it's just getting started," the analyst tells investors in a research note.
Roth MKM
Chip Moore
Strong Buy
Maintains
$36 → $31
2024-11-08
Reason
Piper Sandler
Alexander Potter
Buy
Maintains
$36 → $33
2024-10-22
Reason
Piper Sandler analyst Alexander Potter lowered the firm's price target on Aspen Aerogels to $33 from $36 and keeps an Overweight rating on the shares. The firm notes its price target is moving lower to reflect dilution, but it continues to recommend Aspen Aerogels shares. With the balance sheet overhang now fully addressed, Piper thinks investors can start looking forward to new customer awards and construction milestones at Aspen's new factory in Georgia.
Valuation Metrics
The current forward P/E ratio for Aspen Aerogels Inc (ASPN.N) is 39.56, compared to its 5-year average forward P/E of 7.66. For a more detailed relative valuation and DCF analysis to assess Aspen Aerogels Inc 's fair value, click here.
Forward PE

N/A
5Y Average PE
7.66
Current PE
39.56
Overvalued PE
62.07
Undervalued PE
-46.75
Forward EV/EBITDA

N/A
5Y Average EV/EBITDA
-19.36
Current EV/EBITDA
6.91
Overvalued EV/EBITDA
33.99
Undervalued EV/EBITDA
-72.71
Forward PS

Fair
5Y Average PS
3.95
Current PS
1.12
Overvalued PS
6.85
Undervalued PS
1.05
Financials
Annual
Quarterly
FY2024Q4
YoY :
+46.15%
123.09M
Total Revenue
FY2024Q4
YoY :
+1022.27%
15.52M
Operating Profit
FY2024Q4
YoY :
-2289.21%
11.36M
Net Income after Tax
FY2024Q4
YoY :
-1500.00%
0.14
EPS - Diluted
FY2024Q4
YoY :
-168.49%
20.93M
Free Cash Flow
FY2024Q4
YoY :
+8.87%
38.29
Gross Profit Margin - %
FY2024Q4
YoY :
-90.16%
-8.99
FCF Margin - %
FY2024Q4
YoY :
-1588.71%
9.23
Net Margin - %
FY2024Q4
3.45
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
2.9M
USD
2
0-12
Months
98.2M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
651.7K
Volume
4
Bought
0-3
0
0.0
Volume
Months
3-6
3
821.1K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ASPN News & Events
Events Timeline
2025-04-08 (ET)
News
7.0
04-01NASDAQ.COMLobbying Update: $40,000 of ASPEN AEROGELS INC. lobbying was just disclosed
1.0
03-04PRnewswireAspen Aerogels to Present at the 37th Annual ROTH Conference
4.0
02-14BenzingaRoth MKM Maintains Buy on Aspen Aerogels, Lowers Price Target to $16
9.5
02-14BenzingaAspen Aerogels Analysts Slash Their Forecasts After Q4 Earnings
4.0
02-14BenzingaCraig-Hallum Maintains Buy on Aspen Aerogels, Lowers Price Target to $18
4.0
02-14Business InsiderAspen Aerogels price target lowered to $13 from $32 at Oppenheimer
9.5
02-13Business InsiderCisco jumps after earnings beat, Trump teases reciprocal tariffs: Morning Buzz
2.0
02-13BenzingaTrade Desk Posts Downbeat Revenue, Joins Aspen Aerogels, Fastly And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
4.0
02-13BenzingaThis Kraft Heinz Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
4.0
02-13BenzingaSeaport Global Downgrades Aspen Aerogels to Neutral
9.5
02-13BenzingaWhy AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
4.0
02-13Business InsiderAspen Aerogels downgraded to Neutral from Buy at Seaport Research
4.0
02-13Business InsiderAspen Aerogels (ASPN) was downgraded to a Hold Rating at Seaport Global
7.0
02-12Investing.comAspen Aerogels shares plunge on weak Q1 guidance By Investing.com
4.0
02-11Business InsiderAspen Aerogels (ASPN) Receives a Buy from Craig-Hallum
4.0
02-10Business InsiderRoth MKM Reaffirms Their Buy Rating on Aspen Aerogels (ASPN)
4.0
01-30Business Insider3 Best Stocks to Buy Now, 1/30/2025, According to Top Analysts
7.0
01-28Business InsiderAspen Aerogels announces agreement with AMA
7.0
01-28PRnewswireAspen Aerogels Reaches Settlement with AMA to Resolve Patent Case
2.0
01-23NewsfilterAspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
People Also Watch

SBGI
Sinclair Inc
13.370
USD
+0.60%

GOGO
Gogo Inc
6.620
USD
-6.63%

PHVS
Pharvaris NV
11.830
USD
-10.45%

EH
EHang Holdings Ltd
15.410
USD
-7.11%

AGRO
Adecoagro SA
10.460
USD
+0.58%

WOLF
Wolfspeed Inc
2.180
USD
-15.83%

BBAI
BigBear.ai Holdings Inc
2.660
USD
-9.22%

TRS
TriMas Corp
19.900
USD
-2.74%

BKD
Brookdale Senior Living Inc
5.130
USD
-8.23%

FWRD
Forward Air Corp
10.500
USD
-15.66%
FAQ

What is Aspen Aerogels Inc (ASPN) stock price today?
The current price of ASPN is 5.02 USD — it has decreased -5.99 % in the last trading day.

What is Aspen Aerogels Inc (ASPN)'s business?

What is the price predicton of ASPN Stock?

What is Aspen Aerogels Inc (ASPN)'s revenue for the last quarter?

What is Aspen Aerogels Inc (ASPN)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Aspen Aerogels Inc (ASPN)'s fundamentals?

How many employees does Aspen Aerogels Inc (ASPN). have?
